GHRS

Gh Research Plc

• Reuters·04/02 21:52

  GH Research files Form 3 for COO Cameron Aaron Luke beneficial ownership statement

• Reuters·04/02 21:43

  GH Research files Form 3; Director Dermot Hanley reports beneficial ownership

• Reuters·04/02 21:36

  GH Research files Form 3 for Ireland managing director Halle Magnus Clemensen

• Reuters·04/02 21:36

  GH Research director Michael Forer files initial beneficial ownership statement

• Reuters·04/02 21:35

  GH Research files Form 3 showing CEO Velichka Valcheva beneficial ownership

• Reuters·04/02 21:33

  GH Research files Form 3 for VP Finance Julie Ryan beneficial ownership

• Reuters·04/01 20:02

  GH Research files Form 3 as director Florian Schonharting reports beneficial ownership

• NASDAQ·03/28 02:01

  GH Research (GHRS) Price Target Increased by 18.94% to 40.04

• Benzinga·03/27 17:28

  'Bipartisan Senators File Bill To Support Psychedelics Research And Treatment For Veterans' - Marijuana Moment

• TipRanks·03/26 15:00

  Psychedelic: Compass Pathways, NRx Pharma report earnings results

• TipRanks·03/25 15:49

  GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy

• TipRanks·03/25 15:15

  GH Research announces publication of Phase 2b results for mebufotenin

• Benzinga·03/25 15:14

  GH Research Announces Two-Peer Reviewed Publications From Its Phase 2B Clinical Program Of GH001 For Treatment-Resistant Depression

• Reuters·03/25 15:10

  GH Research announces JAMA Psychiatry publication of Phase 2b GH001 results in treatment-resistant depression; reports efficacy independent of prior antidepressant failures

• Reuters·03/16 11:38

  GH Research to join fireside chat at Stifel Virtual CNS Forum